GlassScriptPhysician profile
Perin Alfred
NPI 1285691980
$2,908.61
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.92 · 2020: $317 · 2021: $408 · 2022: $317 · 2023: $896 · 2024: $759 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Education: $32.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.02 |
| Education | $32.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,252.98 | 2019-2025 | Breztri, Airsupra, Symbicort |
| Glaxosmithkline, LLC. | $1,111.96 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.61 | 2022-2024 | Stiolto Respimat, Ofev |
| Electromed, INC. | $108.13 | 2023-2024 | Smartvest |
| Inogen, INC. | $78.32 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| United Therapeutics Corporation | $70.54 | 2024-2025 | Tyvaso, Tyvaso |
| Pulmonx Corporation | $56.27 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Actelion Pharmaceuticals US, INC. | $43.13 | 2024-2025 | Opsumit |
| Insmed, INC. | $32.48 | 2024 | Arikayce |
| Intuitive Surgical, INC. | $16.99 | 2022 | |
| Philips North America LLC | $12.77 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.43 | 2023 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,589,836.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perin Alfred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.